Amyotrophic Lateral Sclerosis

A combination of two experimental drugs appears to slow the decline of patients with amyotrophic lateral sclerosis, an illness often known as ALS or Lou Gehrig's disease.

A six-month study of 137 patients with a fast-progressing form of the disease found that those who got daily doses of a two-drug combination called AMX0035 scored several points higher on a standard measure of function, a team reports in the Sept. 3 issue of The New England Journal of Medicine.

The state Medical Board is accepting new petitions through December 31 seeking to add illnesses as qualifying conditions for medical marijuana.

Former Cleveland Browns general manager Dwight Clark has passed away from complications of ALS.